The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis

BACKGROUND: To assess the efficacy of Nimotuzumab in combination with first-line chemoradiotherapy treatment in Chinese patients with primary III-IVb stage nasopharyngeal carcinoma. METHODS: Patients with primary locoregionally advanced nasopharyngeal carcinoma who were treated with intensity-modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhi-Qiang, Wang, Qi, Mei, Ji-Bin, Li, Rui, You, You-Ping, Liu, Rui, Sun, Guang-Yuan, Hu, Ming-Yuan, Chen, Yi-Jun, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862826/
https://www.ncbi.nlm.nih.gov/pubmed/31744469
http://dx.doi.org/10.1186/s12885-019-6156-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862826/
https://www.ncbi.nlm.nih.gov/pubmed/31744469
http://dx.doi.org/10.1186/s12885-019-6156-5

Ejemplares similares